Porton Pharma Solutions Balance Sheet Health
Financial Health criteria checks 5/6
Porton Pharma Solutions has a total shareholder equity of CN¥5.9B and total debt of CN¥1.3B, which brings its debt-to-equity ratio to 22.4%. Its total assets and total liabilities are CN¥9.2B and CN¥3.3B respectively.
Key information
22.4%
Debt to equity ratio
CN¥1.33b
Debt
Interest coverage ratio | n/a |
Cash | CN¥1.81b |
Equity | CN¥5.95b |
Total liabilities | CN¥3.26b |
Total assets | CN¥9.21b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 300363's short term assets (CN¥3.4B) exceed its short term liabilities (CN¥1.4B).
Long Term Liabilities: 300363's short term assets (CN¥3.4B) exceed its long term liabilities (CN¥1.9B).
Debt to Equity History and Analysis
Debt Level: 300363 has more cash than its total debt.
Reducing Debt: 300363's debt to equity ratio has reduced from 34.7% to 22.4% over the past 5 years.
Debt Coverage: 300363's debt is well covered by operating cash flow (26.1%).
Interest Coverage: Insufficient data to determine if 300363's interest payments on its debt are well covered by EBIT.